NCT04539964: A trial that was reported late by SetPoint Medical Corporation
This trial has reported, although it was 115 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT04539964 |
|---|---|
| Title | Vagus Nerve Stimulation Using the SetPoint System for Moderate to Severe Rheumatoid Arthritis: The RESET-RA Study |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Jan. 11, 2021 |
| Completion date | May 16, 2024 |
| Required reporting date | May 16, 2025, midnight |
| Actual reporting date | Sept. 8, 2025 |
| Date last checked at ClinicalTrials.gov | May 29, 2026 |
| Days late | 115 |